Cancer immunology is a field of study that focuses on understanding the interactions between the immune system and cancer cells. The immune system plays a crucial role in recognizing and eliminating abnormal cells, including cancerous ones. Research in cancer immunology aims to decipher the complex interplay between cancer and the immune system. Key concepts include immunosurveillance, which describes the immune system's ability to recognize and eliminate cancer cells, and immune evasion, where tumors develop strategies to escape immune responses. Immunotherapies have emerged as a groundbreaking approach in cancer treatment, leveraging the body's immune system to target and destroy cancer cells. Checkpoint inhibitors, adoptive cell therapies, and cancer vaccines are among the innovative immunotherapeutic strategies being developed to enhance immune responses against cancer. Understanding the tumor microenvironment, immune cell activation, and the role of immunosuppressive factors are critical in advancing cancer immunology. Ongoing research in this field holds promise for the development of more effective and personalized immunotherapies, revolutionizing cancer treatment and improving patient outcomes.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States